Wells Fargo & Company »

Ovid Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 449k 3.22
2023-09-30 $1.7M 445k 3.84
2023-06-30 $1.5M 451k 3.28
2022-12-31 $798k 429k 1.86
2022-09-30 $1.1M 435k 2.52
2022-06-30 $1.2M 432k 2.75
2022-03-31 $1.4M 435k 3.14
2021-12-31 $1.5M 452k 3.21
2021-09-30 $1.5M 454k 3.36
2021-06-30 $1.8M 454k 3.91
2021-03-31 $1.8M 458k 4.02
2020-12-31 $1.3M 552k 2.30
2020-09-30 $3.1M 535k 5.77
2020-06-30 $3.8M 520k 7.39
2020-03-31 $2.6M 490k 5.32
2019-12-31 $2.0M 474k 4.15
2019-09-30 $1.4M 422k 3.24
2019-06-30 $660k 443k 1.49
2019-03-31 $546k 314k 1.74
2018-12-31 $17k 6.9k 2.46
2018-09-30 $39k 6.9k 5.61
2018-06-30 $51k 6.5k 7.83
2018-03-31 $48k 6.8k 7.02
2017-12-31 $8.0k 785 10.19